Need:
Quickly optimize the concept for a home COVID test and future app, including features, visualized instructions for use, reasons-to-believe, and how best to communicate clearly and allay concern
Approach:
Two, 1-hour sessions of n=20–25 to gain insight on the concept and materials with more reliable, unbiased input than traditional qual groups, identifying advantages versus category expectations
A third session of n=25 was fielded a few weeks later to delve into one potential add-on offering
Follow-up quantitative concept tests were conducted in US, UK, Canada, Germany, and Brazil
(for BinaxNOW and Panbio)
Outcomes:
BinaxNOW and Panbio were launched in 2020 and 2021, and delivered ~$2B in sales per quarter!
BinaxNOW was the #1 US non-food product launch of 2022!